adenosine monophosphate has been researched along with Epilepsy in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YC; Du, TT; Liu, DF; Liu, YY; Yuan, TS; Zhang, JG; Zhang, X; Zhu, GY | 1 |
| Chandra, PP; Jain, S; Potschka, H; Tripathi, M; Vohora, D | 1 |
| Chiarugi, A; Coppi, E; Muzzi, M; Pugliese, AM | 1 |
| Balestri, P; Grosso, S; Luddi, A; Marchi, F; Margollicci, M; Rocchi, R; Vatti, G | 1 |
| Bogo, MR; Bonan, CD; Bruno, AN; Cognato, Gde P; da Silva, RS; Sarkis, JJ | 1 |
| Brodie, MJ; Ross, FM; Stone, TW | 1 |
| Cherchenko, AP; Todor, IM | 1 |
1 review(s) available for adenosine monophosphate and Epilepsy
| Article | Year |
|---|---|
Management of COVID-19 in patients with seizures: Mechanisms of action of potential COVID-19 drug treatments and consideration for potential drug-drug interactions with anti-seizure medications.
Topics: Adenosine Monophosphate; Alanine; Amides; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Anticonvulsants; Antiviral Agents; Chloroquine; COVID-19; COVID-19 Drug Treatment; Cytochrome P-450 CYP3A Inducers; Dexamethasone; Drug Combinations; Drug Interactions; Enzyme Inhibitors; Epilepsy; Glucocorticoids; Humans; Hydroxychloroquine; Interleukin 1 Receptor Antagonist Protein; Ivermectin; Lopinavir; Pyrazines; Ritonavir; SARS-CoV-2 | 2021 |
6 other study(ies) available for adenosine monophosphate and Epilepsy
| Article | Year |
|---|---|
Anterior thalamic nuclei deep brain stimulation inhibits mossy fiber sprouting via 3',5'-cyclic adenosine monophosphate/protein kinase A signaling pathway in a chronic epileptic monkey model.
Topics: Adenosine Monophosphate; Anterior Thalamic Nuclei; Cyclic AMP-Dependent Protein Kinases; Deep Brain Stimulation; Epilepsy; Epilepsy, Temporal Lobe; Hippocampus; Humans; Mossy Fibers, Hippocampal; Signal Transduction | 2021 |
Anticonvulsant effect of AMP by direct activation of adenosine A1 receptor.
Topics: Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine Monophosphate; Animals; Anticonvulsants; CA1 Region, Hippocampal; Disease Models, Animal; Epilepsy; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Organ Culture Techniques; Receptor, Adenosine A1; Xanthines | 2013 |
Postictal serum nucleotidases activities in patients with epilepsy.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Adolescent; Adult; Child; Electroencephalography; Epilepsy; Female; Humans; L-Lactate Dehydrogenase; Male; Nucleotidases; Statistics, Nonparametric; Thymidine Monophosphate; Time Factors; Young Adult | 2009 |
Antiepileptic drugs prevent changes induced by pilocarpine model of epilepsy in brain ecto-nucleotidases.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Anticonvulsants; Brain; Carbamazepine; Cerebral Cortex; Epilepsy; Hippocampus; Male; Muscarinic Agonists; Phenytoin; Pilocarpine; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Synaptosomes; Valproic Acid | 2007 |
Adenosine monophosphate as a mediator of ATP effects at P1 purinoceptors.
Topics: 5'-Nucleotidase; Adenosine Deaminase; Adenosine Monophosphate; Adenosine Triphosphate; AMP Deaminase; Animals; Electrophysiology; Epilepsy; Hippocampus; In Vitro Techniques; Male; Rats; Rats, Wistar; Receptors, Purinergic P1 | 1998 |
[Changes in energy metabolism in the brain of bemegride-kindled rabbits].
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Animals; Bemegride; Cerebral Cortex; Convulsants; Disease Models, Animal; Energy Metabolism; Epilepsy; Kindling, Neurologic; Male; Mitochondria; Oxygen; Rabbits | 2002 |